Aberrant methylation patterns can disrupt this balance; for instance, hypermethylation may silence the OPG gene, thereby promoting osteoclast activation and bone resorption, while hypomethylation of osteolytic genes such as RANKL may enhance bone degradation and tumor-induced osteolysis [54]. The gene discussed is TNFSF11; the disease is neoplasm.